Heparin for adhesion prevention: Comparison of three different dosages with Seprafilm in a murine model

International Journal of Surgery

Volumn 9, Issue 3, 2011, Pages 225-228

  Kement, Metin ^a   Censur, Zafer ^a   Oncel, Mustafa ^a,b   Buyukokuroglu, Mehmet E ^c   Gezen, Fazli C ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b GUMUSHANE UNIVERSITY   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Adhesions; Heparin; Seprafilm

Indexed keywords

CARBOXYMETHYLCELLULOSE; HEPARIN; HYALURONIC ACID; NEVPARIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONITIS; PRIORITY JOURNAL; RANDOMIZATION; SCORING SYSTEM; TISSUE ADHESION; TREATMENT OUTCOME;

ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; HEPARIN; HYALURONIC ACID; MEMBRANES, ARTIFICIAL; MICE; MICE, INBRED BALB C; TISSUE ADHESIONS;

EID: 79953327478     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2010.11.016     Document Type: Article

References (21)

1. Risberg B. Adhesions preventive strategies. Eur J Surg Suppl 1997, 577:32-39.
2. Ellis H. The magnitude of adhesion related problems. Ann Chir Gynaecol 1998, 1:9-11.
3. Ray N.F., Denton W.G., Thamer M., Hernderson S.C., Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the U.S. in 1994. J Am Coll Surg 1998, (186):1-9.
4. Hammoud A., Gago L.A., Diamond M.P. Adhesions in patients with chronic pelvic pain: a role for adhesiolysis?. Fertil Steril 2004, 82:1483-1491.
5. Peters A.A., Trimbos-Kemper G.C., Admiraal C., Trimbos J.B., Hermans J. A randomized clinical trial on the benefit of adhesiolysis in patients with intraperitoneal adhesions and chronic pelvic pain. Br J Obstet Gynaecol 1992, 99:59-62.
6. Ray N.F., Larsen J.W., Stillman R.J., Jacobs R.J. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993, 176:271-277.
7. Oncel M., Remzi F.H., Senagore A.J., Connor J.T., Fazio V.W. Comparison of a novel liquid (Adcon-P) and a sodium hyaluronate and carboxymethylcellulose membrane (Seprafilm) in postsurgical adhesion formation in a murine model. Dis Colon Rectum 2003, 46:187-191.
8. Gandhi N.S., Mancera R.L. The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 2008, 72:455-482.
9. Kutlay J., Ozer Y., Isik B., Kargici H. Comparative effectiveness of several agents for preventing postoperative adhesions. World J Surg 2004, 28:662-665.
10. Mazuji M.K., Calambaheti K., Pover B. Prevention of adhesion with polivinil pyrrolidone. Arch Surg 1964, 89:1011-1015.
11. Oncel M., Remzi F.H., Connor J., Fazio V.W. Comparison of cecal abrasion and multiple abrasion models in generating intra-abdominal adhesions for animal studies. Tech Coloproctol 2005, 9:29-33.
12. Fazio V.W., Cohen Z., Fleshman J.W., van Goor H., Bauer J.J., Wolff B.G., et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 2006, 49:1-11.
13. Beck D.E., Cohen Z., Fleshman J.W., Kaufman H.S., van Goor H., Wolff B.G. Adhesion Study Group Steering Committee. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 2003, 46:1310-1319.
14. Remzi F.H., Oncel M., Church J.M., Senagore A.J., Delaney C.P., Fazio V.W. An unusual complication after hyaluronatebased bioresorbable membrane (Seprafilm) application. Am Surg 2003, 69:356-357.
15. Holmdahl L. Making and covering of surgical footprints. Lancet 1999, 53:1456-1457.
16. Thompson J.N., Whawell S.A. Pathogenesis and prevention of adhesion formation. Br J Surg 1995, 82:3-5.
17. Turkcapar A.G., Ozarslan C., Erdem E., Bumin C., Erverdi N., Kutlay J. The effectiveness of low molecular weight heparin on adhesion formation in experimental rat model. Int Surg 1995, 80:92-94.
18. Arikan S., Adas G., Barut G., Toklu A.S., Kocakusak A., Uzun H., et al. An evaluation of low molecular weight heparin and hyperbaric oxygen treatment in the prevention of intra-abdominal adhesions and wound healing. Am J Surg 2005, 189:155-160.
19. Erke H.P., Fjellner B., Hagermark O. Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions. Int J Immunopharmacol 1986, 8:277-286.
20. Bahadir I., Oncel M., Kement M., Sahip Y. Intra-abdominal use of taurolidine or heparin as alternative products to an antiadhesive barrier (Seprafilm) in adhesion prevention: an experimental study on mice. Dis Colon Rectum 2007, 50:2209-2214.
21. Buxton I.L.O. Pharmacokinetics and Pharmacodynamics. Goodman and Gilman's the Pharmacological Basis of Therapeutics 2006, 1-39. McGraw-Hill, New York. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).